CD19 CAR-T cells Clinical Trials
7 recruitingDrug
Phase 15Phase 24
Showing 1–7 of 7 trials
Recruiting
Phase 2
CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma
Large B-Cell Lymphoma (LBCL)
Zhejiang University40 enrolled1 locationNCT04661020
Recruiting
Phase 1Phase 2
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
Autoimmune Diseases
Beijing GoBroad Hospital18 enrolled1 locationNCT06688799
Recruiting
Phase 1Phase 2
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Beijing GoBroad Hospital18 enrolled1 locationNCT06585514
Recruiting
Phase 1
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd18 enrolled1 locationNCT07331467
Recruiting
Phase 2
A Multicenter Study of CAR-T Cells in Primary Ph+All
ALL
Zhejiang University50 enrolled1 locationNCT07252336
Recruiting
Phase 1
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine18 enrolled1 locationNCT07233642
Recruiting
Phase 1
Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematous (SLE)
National University of Malaysia5 enrolled1 locationNCT06710717